J&J Buyout Of Merck OTC Unit Clears European Commission
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson cleared its final regulatory hurdle toward the acquisition of Merck's stake in the nonprescription drug joint venture following European Commission approval, announced March 30